1. Home
  2. RCKT vs PLUG Comparison

RCKT vs PLUG Comparison

Compare RCKT & PLUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • PLUG
  • Stock Information
  • Founded
  • RCKT 1999
  • PLUG 1997
  • Country
  • RCKT United States
  • PLUG United States
  • Employees
  • RCKT N/A
  • PLUG N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • PLUG Industrial Machinery/Components
  • Sector
  • RCKT Health Care
  • PLUG Energy
  • Exchange
  • RCKT Nasdaq
  • PLUG Nasdaq
  • Market Cap
  • RCKT 326.4M
  • PLUG 1.6B
  • IPO Year
  • RCKT N/A
  • PLUG 1999
  • Fundamental
  • Price
  • RCKT $2.59
  • PLUG $1.41
  • Analyst Decision
  • RCKT Buy
  • PLUG Hold
  • Analyst Count
  • RCKT 13
  • PLUG 16
  • Target Price
  • RCKT $18.50
  • PLUG $1.76
  • AVG Volume (30 Days)
  • RCKT 4.5M
  • PLUG 107.6M
  • Earning Date
  • RCKT 08-04-2025
  • PLUG 08-07-2025
  • Dividend Yield
  • RCKT N/A
  • PLUG N/A
  • EPS Growth
  • RCKT N/A
  • PLUG N/A
  • EPS
  • RCKT N/A
  • PLUG N/A
  • Revenue
  • RCKT N/A
  • PLUG $642,224,000.00
  • Revenue This Year
  • RCKT N/A
  • PLUG $17.73
  • Revenue Next Year
  • RCKT N/A
  • PLUG $26.15
  • P/E Ratio
  • RCKT N/A
  • PLUG N/A
  • Revenue Growth
  • RCKT N/A
  • PLUG N/A
  • 52 Week Low
  • RCKT $2.19
  • PLUG $0.69
  • 52 Week High
  • RCKT $26.98
  • PLUG $3.34
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 31.97
  • PLUG 60.21
  • Support Level
  • RCKT $2.56
  • PLUG $1.09
  • Resistance Level
  • RCKT $2.70
  • PLUG $1.57
  • Average True Range (ATR)
  • RCKT 0.20
  • PLUG 0.15
  • MACD
  • RCKT 0.10
  • PLUG 0.02
  • Stochastic Oscillator
  • RCKT 10.22
  • PLUG 63.19

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About PLUG Plug Power Inc.

Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.

Share on Social Networks: